drugset / Trial / NCT05517616
The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-center, open-label, single-dose clinical pharmacokinetic study. The purpose of this study is to investigate the absorption properties, as well as to evaluate the mass balance and elucidate the pathways of biotransformation after a single oral dose of 400mg, 200μCi \[14C\] APG-2575 to healthy subjects.
Timeline
- Start
- 2022-09-14
- Primary completion
- 2022-11-01
- Completion
- 2023-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APG-2575 | Small molecule | 400 mg | Oral |
Indications
No indication recorded.